Quantcast Cellect Biotechnology Ltd Stock Quote | Stock Price for APOP | Financial News | myMotherLode.com

Financial News

Motherlode Stocks
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Cellect Biotechnology Ltd (NQ: APOP)
3.140 USD  -0.050 (-1.57%)
Streaming Delayed Price  /  Updated: 9:44 AM EST, Dec 12, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 5,754
Open 3.150
Bid (Size) 3.120 (5)
Ask (Size) 3.150 (4)
Prev. Close 3.190
Today's Range 3.140 - 3.150
52wk Range 3.000 - 13.50
Shares Outstanding 6,509,639
Dividend Yield N/A
Performance
YTD
-59.48%
-59.48%
1 Month
-31.25%
-31.25%
3 Month
-37.20%
-37.20%
6 Month
-56.81%
-56.81%
1 Year
-58.30%
-58.30%
Top News
More News
Investor Expectations to Drive Momentum within Atomera, YogaWorks, Cellect Biotechnology, Eyegate Pharmaceuticals, Zealand Pharma A/S, and Polar Power — Discovering Underlying Factors of Influence
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Atomera Incorporated... Read More
from GlobeNewswire News Releases
Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial Results
Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results... Read More
from PR Newswire
More News
Read More
Cellect Receives Multiple Patent Grants
from PR Newswire
Cellect to Present Its Breakthrough Stem Cell Production Technology at the BIO-Europe
from PR Newswire
Cellect Announces a Major Technological Breakthrough for Industrialization of Apotainer™ Stem Cell Product Line
from PR Newswire
Positive Results of Orthopedic Treatment With the Use of ApoGraft™ Enriched Stem Cells Derived From Fat Tissues
from PR Newswire
Cellect Announces Positive Clinical Results
from PR Newswire
Cellect Receives Notice of Allowance for Stem Cell Selection Technology Patent in Korea
from PR Newswire
Cellect and Cell2in Launch Collaboration to Significantly Improve Stem Cell Selection and Expansion
from PR Newswire
Cellect Biotechnology Provides Corporate Update and Reports Second Quarter 2018 Financial Results
from PR Newswire
Cellect Granted Key European Patent for Its Stem Cell Selection Technology
from PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Follow myMotherLode.com at these social networks Make Us Your Homepage Today Follow us on Facebook Follow us on Twitter Follow us on Youtube Follow us on LinkedIn Follow our RSS Feed
Yellow Pages

Popular Searches

Local Radio Stations
© Copyright 2000-2017 Clarke Broadcasting Corporation. All rights reserved.